ANN INTERN MED 润色咨询

ANNALS OF INTERNAL MEDICINE

出版年份：暂无数据 年文章数：1837 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：3.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2022-06-29 ms2000001425378496

    期刊送外审稿几率大不大？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2022-07-16 1220023cm59(暂无昵称)

    今年有希望发一篇

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    所有作者在文章接收之后都会接收到邮件吗？

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2014-06-18 匿名用户

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2021-07-12 遗忘爱神

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向： 内科学
    经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2022-03-16 ms7000000213952934

    投稿命中率:5.0
    经验分享：医学顶刊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2022-02-08 ms1000001519491719

    请问作者投稿要求能发个链接不

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    期刊可以有几个通讯作者/第一作者？

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2017-09-14 mileo

    acceptance rate <7.5%

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1229501, encodeId=af0a12295016c, content=期刊送外审稿几率大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1578, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Wed Jun 29 16:58:24 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232764, encodeId=a0221232e6423, content=今年有希望发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134d2298591, createdName=1220023cm59(暂无昵称), createdTime=Sat Jul 16 10:37:35 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086734, encodeId=807c1086e342e, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503634, encodeId=a85c50363477, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：国内以前发表过几篇文章，包括一个中药麻杏石甘汤治疗甲流的，另外，今年上海六院李明华也发了一个脑血管瘤的流行病学调查资料。其它的团队发表并不多，这个期刊国内发的还相对较少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1711, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 18 12:32:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998854, encodeId=c3fb99885438, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向： 内科学 <br>经验分享：最近投稿了一篇，两个审稿人的意见都可以，编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=986, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Mon Jul 12 18:31:36 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203158, encodeId=1f12120315816, content=投稿命中率:5.0<br>经验分享：医学顶刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e42a5400022, createdName=ms7000000213952934, createdTime=Wed Mar 16 17:35:53 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191059, encodeId=c4dc1191059aa, content=请问作者投稿要求能发个链接不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=844, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4496159038, createdName=ms1000001519491719, createdTime=Tue Feb 08 16:01:50 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086733, encodeId=d8db1086e33ef, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=947, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547118, encodeId=ce1e54e1188c, content=acceptance rate <7.5%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1583, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Thu Sep 14 00:17:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544456, encodeId=39ee544456f7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2017-07-16 gu_8183

    谁能预测明年会有多少分?

    0

共18条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分